Anchen Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of extended release (ER) generic products; primarily for patients in the United States.
Anchen takes prides in its creativity and speed in filing Abbreviated New Drug Applications (ANDAs) containing so-called "Paragraph IV" certifications, which seek FDA approval to market generic drugs that avoid patents covering branded products. Creativity and speed have become key components of Anchen’s corporate culture.
Anchen’s goal is to become a fully-integrated drug development, production, and sales company, where employees enjoy their work and have opportunities to make meaningful contributions to the company’s success. In addition to the financial rewards of being a part of Anchen’s success, employees take satisfaction in knowing they have helped deliver more affordable drugs to consumers.